4//SEC Filing
Brown Regina 4
Accession 0001493152-24-042951
CIK 0001335105other
Filed
Oct 28, 8:00 PM ET
Accepted
Oct 29, 5:42 PM ET
Size
12.9 KB
Accession
0001493152-24-042951
Insider Transaction Report
Form 4
Brown Regina
Director
Transactions
- Award
Options to Purchase Common Stock
2024-09-30+6,269→ 6,269 totalExercise: $1.30From: 2024-09-30Exp: 2029-09-30→ Common (6,269 underlying)
Holdings
- 10,000
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (10,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $30.30From: 2021-06-30Exp: 2026-06-30→ Common (10,000 underlying) - 4,904
Options to Purchase Common Stock
Exercise: $2.37From: 2024-06-30Exp: 2029-06-30→ Common (4,904 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $7.45From: 2022-06-30Exp: 2027-06-30→ Common (10,000 underlying) - 25,000
Options to Purchase Common Stock
Exercise: $28.00From: 2021-05-11Exp: 2026-05-11→ Common (25,000 underlying) - 10,000
Options to Purchase Common Stock
Exercise: $5.88From: 2023-06-30Exp: 2028-06-30→ Common (10,000 underlying)
Footnotes (1)
- [F1]Effective September 30, 2024, the reporting person was granted stock options to purchase an aggregate of 6,296 shares vesting immediately. The grant was in lieu of the quarterly cash compensation due to the reporting person under the Board Compensation Plan.
Documents
Issuer
LIXTE BIOTECHNOLOGY HOLDINGS, INC.
CIK 0001335105
Entity typeother
Related Parties
1- filerCIK 0001862089
Filing Metadata
- Form type
- 4
- Filed
- Oct 28, 8:00 PM ET
- Accepted
- Oct 29, 5:42 PM ET
- Size
- 12.9 KB